CX116
CX116 is an orally active anti-inflammatory agent. CX116 exerts its effects by inhibiting the inflammatory response, reducing oxidative stress, protecting mitochondrial function, and counteracting apoptosis. CX116 bears acceptable toxicity, and can significantly protect renal tissue from Cisplatin -induced damage. CX116 can be used for the study of Cisplatin-induced acute kidney injury (cis-AKI).
Product Specifications
UNSPSC
12352005
Target
Apoptosis
Related Pathways
Apoptosis
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Cancer; Metabolic Disease
Smiles
NC1=NC=C(C=C1C(NC2=CC=C(C=C2)NC(C)=O)=O)C3=CC=C(N=C3)N4CCOCC4
Molecular Formula
C23H24N6O3
Molecular Weight
432.48
References & Citations
[1]Lou Y, et al. Discovery of Novel Potent Molecule for Treating Cisplatin-Induced Acute Kidney Injury Driven by Phenotypic Screening. J Med Chem. 2025 Jun 12;68 (11) :12100-12124.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
A13306-2-Fluoro488 100 µg/Vial
Anti-SYT16 Antibody Picoband® Fluoro488 Conjugated
Sign In for Pricing
View Details 
MBS2109311-01 0.1 mL
FITC-Linked Polyclonal Antibody to Apolipoprotein B (APOB)
Sign In for Pricing
View Details MBS2109311-02 0.2 mL
FITC-Linked Polyclonal Antibody to Apolipoprotein B (APOB)
Sign In for Pricing
View Details MBS2109311-03 0.5 mL
FITC-Linked Polyclonal Antibody to Apolipoprotein B (APOB)
Sign In for Pricing
View Details MBS2109311-04 1 mL
FITC-Linked Polyclonal Antibody to Apolipoprotein B (APOB)
Sign In for Pricing
View Details MBS2109311-05 5 mL
FITC-Linked Polyclonal Antibody to Apolipoprotein B (APOB)
Sign In for Pricing
View Details